HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
  • Awards
  • Advertise
  • Subscribe

Covid-19 PHE Ending on May 11

February 2, 2023 by David Kopf

The Biden Administration has released a statement of policy that it plans to end the Covid-19 public health emergency on May 11, a month longer than the previous extension’s end date.

In January, Secretary of Health and Human Services Xavier Becerra extended the Covid-19 public health emergency for another 90 days until what would be an April 11 expiration date.

The May 11 stop date offers a much longer advance notice than the 60 days’ advance notice before ending the PHE that Secretary of Health and Human Services Xavier Becerra committed to in a May 10, 2022 letter he sent to U.S. governors.

The HME industry has been operating under various policy relaxations and different reimbursement guidelines thanks to the PHE, with the most important being the 75/25 blended rate in non-rural/non-competitive bidding areas. Fortunately, the recently approved omnibus spending package extended the 75/25 blended Medicare rate for non-CBA, non-rural suppliers until at least Dec. 31, 2023.

“Now the HME community can focus on advocacy for further extending the 75/25 rates beyond 2023, as well as increasing Medicare reimbursements for suppliers in former CBAs,” a statement from the American Association for Homecare read. “AAHomecare will also continue to work on maintaining access for oxygen and continuous glucose monitor patients who qualified for these products under PHE coverage guidelines.”

Related Articles Read More >

AAHomecare: Competitive Bidding Won’t Feature ‘Legacy’ Product Categories
CQRC ‘Commends’ Exclusions of Supplemental Oxygen, CPAP from Medicare Competitive Bidding
The Council for Quality Respiratory Care also urged industry support for the SOAR act.
AOPA: Final Rule to Have ‘Significant Impact’ on Orthotics, Prosthetics Providers
OTS knee, spinal and upper-extremity orthoses are included in the remote item delivery portion of the competitive bidding program.
Resmed Announces FDA Clearance for AI Device to Support Sleep Therapy Regimens
The device incorporates artificial intelligence and will be marketed as Smart Comfort.

Get the free newsletter

Home Healthcare Softare

Subscribe to HME Business for industry & product news, trends and resources.
HME Business Directory
HME Podcasts
HME Business
  • Mobility Management
  • Senior Housing News
  • Home Health Care News
  • Skilled Nursing News
  • Hospice News
  • Behavioral Health Business
  • About HME Business
  • Contact Us

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
  • Awards
  • Advertise
  • Subscribe